Folgen
Alberto Lleo
Alberto Lleo
Neurology Department. Hospital Sant Pau. Barcelona.
Bestätigte E-Mail-Adresse bei santpau.es - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452-1458, 2013
43672013
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
22072019
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
15102015
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
9092017
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
8992022
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
7362014
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
6272015
Current pharmacotherapy for Alzheimer's disease
A Lleo, SM Greenberg, JH Growdon
Annu. Rev. Med. 57, 513-533, 2006
4992006
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
4512016
A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L Serenó, M Coma, M Rodriguez, P Sánchez-Ferrer, MB Sánchez, I Gich, ...
Neurobiology of disease 35 (3), 359-367, 2009
4122009
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
3972013
Frontotemporal dementia and its subtypes: a genome-wide association study
R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ...
The Lancet Neurology 13 (7), 686-699, 2014
3792014
Consensus guidelines for lumbar puncture in patients with neurological diseases
S Engelborghs, E Niemantsverdriet, H Struyfs, K Blennow, R Brouns, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 111-126, 2017
3172017
European Alzheimer’s Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer’s Disease; Alzheimer’s Disease Genetic Consortium; Cohorts for Heart and Aging …
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nat Genet 45 (12), 1452-1458, 2013
2922013
A novel Alzheimer disease locus located near the gene encoding tau protein
G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ...
Molecular psychiatry 21 (1), 108-117, 2016
2872016
A multicentre validation study of the diagnostic value of plasma neurofilament light
NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ...
Nature communications 12 (1), 3400, 2021
2822021
Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation
A Lleó, O Berezovska, L Herl, S Raju, A Deng, BJ Bacskai, MP Frosch, ...
Nature medicine 10 (10), 1065-1066, 2004
2822004
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ...
Neurobiology of aging 31 (5), 725-731, 2010
2512010
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
2482018
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
R Guerreiro, OA Ross, C Kun-Rodrigues, DG Hernandez, T Orme, ...
The Lancet Neurology 17 (1), 64-74, 2018
2382018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20